The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy.
 
Paul Nghiem
Honoraria - EMD Serono; Merck Sharp & Dohme
Consulting or Advisory Role - EMD Serono; Pfizer
Research Funding - Bristol-Myers Squibb; EMD Serono
Patents, Royalties, Other Intellectual Property - Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.
 
Shailender Bhatia
Honoraria - EMD Serono; Genentech/Roche
Consulting or Advisory Role - EMD Serono; Genentech/Roche
Research Funding - Bristol-Myers Squibb (Inst); Conkwest (Inst); EMD Serono (Inst); Immune Design (Inst); Merck (Inst); NantWorks (Inst); OncoSec (Inst)
Travel, Accommodations, Expenses - EMD Serono; NantWorks
 
Andrew Scott Brohl
Expert Testimony - GlaxoSmithKline (I)
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Incyte (Inst); macrogenics (Inst); macrogenics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; Boehringer Ingelheim; EMD Serono; Merck; Merck
 
Patrick Terheyden
No Relationships to Disclose
 
Kent C. Shih
No Relationships to Disclose
 
Isaac Brownell
No Relationships to Disclose
 
Celeste Lebbé
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Karl D. Lewis
Research Funding - Merck KGaA
 
Gerald P. Linette
No Relationships to Disclose
 
Michele Milella
Consulting or Advisory Role - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Meliessa Hennessy
Employment - EMD Serono
 
Marcis Bajars
Employment - EMD Serono
 
Christine Hicking
Employment - Merck KGaA
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; GlaxoSmithKline; Immune design; Nektar
Travel, Accommodations, Expenses - Adaptimmune; EMD Serono